
Nureca reported a significant increase in its financial performance for the quarter ended December 2025. Standalone net sales rose approximately 45-50% to around Rs 39.64 crore compared to the previous year, with net profit improving from a loss or marginal profit to between Rs 3.23 crore (standalone) and Rs 3.73 crore (consolidated). EBITDA and operating margins also showed positive growth, reflecting improved operational efficiency. Earnings per share increased slightly to Rs 3.39. Share prices closed at Rs 311.85 on January 14, 2026.
Select a news story to see related coverage from other media outlets.